495 related articles for article (PubMed ID: 3009000)
21. Enhanced therapeutic efficacy of cisplatin by combination with diethyldithiocarbamate and hyperthermia in a mouse model.
Murthy MS; Rao LN; Khandekar JD; Scanlon EF
Cancer Res; 1987 Feb; 47(3):774-9. PubMed ID: 3026616
[TBL] [Abstract][Full Text] [Related]
22. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
23. Protective effects of dithiocarbamates against renal toxicity of cis-diamminedichloroplatinum in rats.
Hidaka S; Tsuruoka M; Funakoshi T; Shimada H; Kiyozumi M; Kojima S
Ren Fail; 1994; 16(3):337-49. PubMed ID: 8059017
[TBL] [Abstract][Full Text] [Related]
24. Water-soluble N-substituted iminodiacetato(1,2-diaminocyclohexane)-platinum(II) complexes as potential antitumor agents.
Hacker MP; Khokhar AR; Krakoff IH; Brown DB; McCormack JJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6250-4. PubMed ID: 3779645
[TBL] [Abstract][Full Text] [Related]
25. Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity.
Esposito M; Vannozzi MO; Viale M; Fulco RA; Collecchi P; Merlo F; De Cian F; Zicca A; Cadoni A; Poirier MC
Carcinogenesis; 1993 Dec; 14(12):2595-9. PubMed ID: 8269632
[TBL] [Abstract][Full Text] [Related]
26. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.
Naganuma A; Satoh M; Imura N
Cancer Res; 1987 Feb; 47(4):983-7. PubMed ID: 3802104
[TBL] [Abstract][Full Text] [Related]
27. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats.
Ohno S; Siddik ZH; Baba H; Stephens LC; Strebel FR; Wondergem J; Khokhar AR; Bull JM
Cancer Res; 1991 Jun; 51(11):2994-3000. PubMed ID: 2032236
[TBL] [Abstract][Full Text] [Related]
28. Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen.
Baldew GS; McVie JG; van der Valk MA; Los G; de Goeij JJ; Vermeulen NP
Cancer Res; 1990 Nov; 50(21):7031-6. PubMed ID: 2208170
[TBL] [Abstract][Full Text] [Related]
29. Protective effects of dithiocarbamates against toxicity of cis-diamminedichloroplatinum in mice.
Shimada H; Takahashi K; Funakoshi T; Kojima S
Biol Pharm Bull; 1993 Apr; 16(4):368-71. PubMed ID: 8358386
[TBL] [Abstract][Full Text] [Related]
30. Cis-diamminedichloroplatinum (II)-procaine pharmacokinetic interaction in mice bearing P388 leukemia.
Esposito M; Vannozzi MO; Viale M; Pellecchia C; Merlo F; Cadoni A; Cafaggi S; Parodi B; Lerza R; Poirier MC
Anticancer Res; 1993; 13(5A):1511-6. PubMed ID: 8239529
[TBL] [Abstract][Full Text] [Related]
31. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
Hirose A; Sato E; Fujii H; Sun B; Nishioka H; Aruoma OI
Toxicol Appl Pharmacol; 2007 Jul; 222(2):152-8. PubMed ID: 17555784
[TBL] [Abstract][Full Text] [Related]
32. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury.
Wondergem J; Bulger RE; Strebel FR; Newman RA; Travis EL; Stephens LC; Bull JM
Cancer Res; 1988 Jan; 48(2):440-6. PubMed ID: 3335012
[TBL] [Abstract][Full Text] [Related]
33. Amelioration of cisplatin-induced nephrotoxicity by the diuretic acetazolamide in F344 rats.
Osman NM; Copley MP; Litterst CL
Cancer Treat Rep; 1984; 68(7-8):999-1004. PubMed ID: 6540145
[TBL] [Abstract][Full Text] [Related]
34. Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats.
Ohno S; Strebel FR; Stephens LC; Siddik ZH; Makino M; Klostergaard J; Tomasovic SP; Khokhar AR; Bull JM
Cancer Res; 1992 Aug; 52(15):4096-101. PubMed ID: 1638521
[TBL] [Abstract][Full Text] [Related]
35. Toxicity of a quinocarmycin analog, DX-52-1, in rats and dogs in relation to clinical outcome.
Mirsalis JC; Schindler-Horvat J; Hill JR; Green CE; Mitoma C; Tomaszewski JE; Tyson CA; Donohue SJ
Cancer Chemother Pharmacol; 2003 Mar; 51(3):193-201. PubMed ID: 12655436
[TBL] [Abstract][Full Text] [Related]
36. Comparative effects of diethyldithiocarbamate, dimercaptosuccinate, and diethylenetriaminepentaacetate on organ distribution and excretion of cadmium.
Gale GR; Atkins LM; Walker EM; Smith AB
Ann Clin Lab Sci; 1983; 13(1):33-44. PubMed ID: 6301355
[TBL] [Abstract][Full Text] [Related]
37. Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.
Terheggen PM; Dijkman R; Begg AC; Dubbelman R; Floot BG; Hart AA; den Engelse L
Cancer Res; 1988 Oct; 48(19):5597-603. PubMed ID: 3046743
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.
Dedon PC; Borch RF
Biochem Pharmacol; 1987 Jun; 36(12):1955-64. PubMed ID: 2954556
[TBL] [Abstract][Full Text] [Related]
39. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts.
Roberts JJ; Friedlos F
Cancer Res; 1987 Jan; 47(1):31-6. PubMed ID: 3791217
[TBL] [Abstract][Full Text] [Related]
40. Further evaluation of diethyldithiocarbamate as an antagonist of cisplatin toxicity.
Gale GR; Atkins LM; Walker EM
Ann Clin Lab Sci; 1982; 12(5):345-55. PubMed ID: 6291445
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]